Selected research
Industry Research
Anti-reflux Infant Formula Industry Research Report 2026
Market perspective
The global Anti-reflux Infant Formula market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-reflux Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-reflux Infant Formula is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-reflux Infant Formula is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-reflux Infant Formula include Aptamil, Bobbie, DANA Dairy, HiPP, Kendal Nutricare, Mead Johnson HCP, Perrigo and SMA Baby Club, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-reflux Infant Formula market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-reflux Infant Formula Market by Company
Aptamil
Bobbie
DANA Dairy
HiPP
Kendal Nutricare
Mead Johnson HCP
Perrigo
SMA Baby Club
Anti-reflux Infant Formula Segment by Type
0-6 Months Infant Formula
6-12 Months Infant Formula
1 Year and Above Infant Formula
Anti-reflux Infant Formula Segment by Application
Online Sales
Offline Sales
Anti-reflux Infant Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-reflux Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-reflux Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-reflux Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-reflux Infant Formula manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-reflux Infant Formula by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-reflux Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0-6 Months Infant Formula
- 6-12 Months Infant Formula
- 1 Year and Above Infant Formula
Applications
- Online Sales
- Offline Sales
Companies covered
- Aptamil
- Bobbie
- DANA Dairy
- HiPP
- Kendal Nutricare
- Mead Johnson HCP
- Perrigo
- SMA Baby Club
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-reflux Infant Formula Market Size (2021-2032)
- 2.2.2 Global Anti-reflux Infant Formula Sales (2021-2032)
- 2.2.3 Global Anti-reflux Infant Formula Market Average Price (2021-2032)
- 2.3 Anti-reflux Infant Formula by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0-6 Months Infant Formula
- 2.3.3 6-12 Months Infant Formula
- 2.3.4 1 Year and Above Infant Formula
- 2.4 Anti-reflux Infant Formula by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-reflux Infant Formula Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-reflux Infant Formula Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Anti-reflux Infant Formula Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-reflux Infant Formula Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-reflux Infant Formula Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-reflux Infant Formula, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-reflux Infant Formula, Product Type & Application
- 3.8 Global Manufacturers of Anti-reflux Infant Formula, Established Date
- 3.9 Global Anti-reflux Infant Formula Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aptamil
- 4.1.1 Aptamil Company Information
- 4.1.2 Aptamil Business Overview
- 4.1.3 Aptamil Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aptamil Anti-reflux Infant Formula Product Portfolio
- 4.1.5 Aptamil Recent Developments
- 4.2 Bobbie
- 4.2.1 Bobbie Company Information
- 4.2.2 Bobbie Business Overview
- 4.2.3 Bobbie Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bobbie Anti-reflux Infant Formula Product Portfolio
- 4.2.5 Bobbie Recent Developments
- 4.3 DANA Dairy
- 4.3.1 DANA Dairy Company Information
- 4.3.2 DANA Dairy Business Overview
- 4.3.3 DANA Dairy Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 DANA Dairy Anti-reflux Infant Formula Product Portfolio
- 4.3.5 DANA Dairy Recent Developments
- 4.4 HiPP
- 4.4.1 HiPP Company Information
- 4.4.2 HiPP Business Overview
- 4.4.3 HiPP Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 HiPP Anti-reflux Infant Formula Product Portfolio
- 4.4.5 HiPP Recent Developments
- 4.5 Kendal Nutricare
- 4.5.1 Kendal Nutricare Company Information
- 4.5.2 Kendal Nutricare Business Overview
- 4.5.3 Kendal Nutricare Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kendal Nutricare Anti-reflux Infant Formula Product Portfolio
- 4.5.5 Kendal Nutricare Recent Developments
- 4.6 Mead Johnson HCP
- 4.6.1 Mead Johnson HCP Company Information
- 4.6.2 Mead Johnson HCP Business Overview
- 4.6.3 Mead Johnson HCP Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mead Johnson HCP Anti-reflux Infant Formula Product Portfolio
- 4.6.5 Mead Johnson HCP Recent Developments
- 4.7 Perrigo
- 4.7.1 Perrigo Company Information
- 4.7.2 Perrigo Business Overview
- 4.7.3 Perrigo Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Perrigo Anti-reflux Infant Formula Product Portfolio
- 4.7.5 Perrigo Recent Developments
- 4.8 SMA Baby Club
- 4.8.1 SMA Baby Club Company Information
- 4.8.2 SMA Baby Club Business Overview
- 4.8.3 SMA Baby Club Anti-reflux Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SMA Baby Club Anti-reflux Infant Formula Product Portfolio
- 4.8.5 SMA Baby Club Recent Developments
5 Global Anti-reflux Infant Formula Market Scenario by Region
- 5.1 Global Anti-reflux Infant Formula Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-reflux Infant Formula Sales by Region: 2021-2032
- 5.2.1 Global Anti-reflux Infant Formula Sales by Region: 2021-2026
- 5.2.2 Global Anti-reflux Infant Formula Sales by Region: 2027-2032
- 5.3 Global Anti-reflux Infant Formula Revenue by Region: 2021-2032
- 5.3.1 Global Anti-reflux Infant Formula Revenue by Region: 2021-2026
- 5.3.2 Global Anti-reflux Infant Formula Revenue by Region: 2027-2032
- 5.4 North America Anti-reflux Infant Formula Market Facts & Figures by Country
- 5.4.1 North America Anti-reflux Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-reflux Infant Formula Sales by Country (2021-2032)
- 5.4.3 North America Anti-reflux Infant Formula Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-reflux Infant Formula Market Facts & Figures by Country
- 5.5.1 Europe Anti-reflux Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-reflux Infant Formula Sales by Country (2021-2032)
- 5.5.3 Europe Anti-reflux Infant Formula Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-reflux Infant Formula Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-reflux Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-reflux Infant Formula Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-reflux Infant Formula Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-reflux Infant Formula Market Facts & Figures by Country
- 5.7.1 South America Anti-reflux Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-reflux Infant Formula Sales by Country (2021-2032)
- 5.7.3 South America Anti-reflux Infant Formula Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anti-reflux Infant Formula Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-reflux Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-reflux Infant Formula Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-reflux Infant Formula Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anti-reflux Infant Formula Sales by Type (2021-2032)
- 6.1.1 Global Anti-reflux Infant Formula Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Anti-reflux Infant Formula Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-reflux Infant Formula Revenue by Type (2021-2032)
- 6.2.1 Global Anti-reflux Infant Formula Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-reflux Infant Formula Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-reflux Infant Formula Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-reflux Infant Formula Sales by Application (2021-2032)
- 7.1.1 Global Anti-reflux Infant Formula Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Anti-reflux Infant Formula Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-reflux Infant Formula Revenue by Application (2021-2032)
- 7.2.1 Global Anti-reflux Infant Formula Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-reflux Infant Formula Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-reflux Infant Formula Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-reflux Infant Formula Value Chain Analysis
- 8.1.1 Anti-reflux Infant Formula Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-reflux Infant Formula Production Mode & Process
- 8.2 Anti-reflux Infant Formula Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-reflux Infant Formula Distributors
- 8.2.3 Anti-reflux Infant Formula Customers
9 Global Anti-reflux Infant Formula Analyzing Market Dynamics
- 9.1 Anti-reflux Infant Formula Industry Trends
- 9.2 Anti-reflux Infant Formula Industry Drivers
- 9.3 Anti-reflux Infant Formula Industry Opportunities and Challenges
- 9.4 Anti-reflux Infant Formula Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst